Static Chart Edesa Biotech, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-11-13 EST			5-day change	1st Jan Change
1.940 ^USD	-6.73%		-9.35%	+36.62%

11-09	Edesa Biotech, Inc. Enters Into Exclusive License Agreement With Kyorin Pharmaceutical Co., Ltd. For Development And Commercialization Of Paridiprubart In Japan	CI
10-15	Edesa Biotech, Inc. Receives FDA IND Clearance For Phase 2 Clinical Study Of EB06 In Vitiligo	CI

Duration

Period